US equities |
MU $1,088.00 ▲+0.00% NVDA $237.47 ▲+0.00% SNDK $1,692.42 ▲+0.00% GOOGL $350.50 ▲+0.00% INTC $113.12 ▲+0.00% META $721.31 ▲+0.00% AMD $645.86 ▲+0.00% SPCX $167.60 ▲+0.00%
FinancialContent

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

70.35 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
3 Stocks Poised to Disrupt the Healthcare Market by 2030 ↗
The old healthcare model is breaking down. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI (TEM) Q1 2026 Earnings Transcript ↗
Tempus AI (TEM) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
Tempus AI Inc. (NASDAQ:TEM) Tumbles After Q1 Revenue Miss Despite EPS Beat and Raised Guidance ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Tempus Reports First Quarter 2026 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Host Inaugural Investor Day on May 29, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Tempus to Report First Quarter 2026 Financial Results on May 5
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
From Tempus AI, Inc.
Via Business Wire
News headline image
2 AI Healthcare Stocks to Buy Right Now ↗
The convergence of two already fantastic industries is creating an incredible opportunity. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
MarketBeat Week in Review – 02/23 - 02/27 ↗
Sometimes the best offense is a good defense. That’s what investors seem to be feeling. Technology stocks continue to be under pressure, and that money is flowing into traditionally defensive assets... 
Via MarketBeat
News headline image
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Reports Fourth Quarter and Full Year 2025 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >